Rubella or German measles is a serious condition (disease) caused by the infection of rubivirus (genus). Sometimes rubella when passed from pregnant mother to her baby then it is termed as congenital rubella. Rubella is a contagious disease and can spread through air or close contact between patient and a healthy individual.
Albany, NY -- (SBWIRE) -- 06/12/2017 -- Recently, due to the rising number of infants born with congenital rubella syndrome or CRS, the business for rubella virus diagnosis has boomed across the global medical sector at a phenomenal pace. Recognizing this great feat, a new research report titled as "Rubella Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024" has been published in the vast online collection of Market Research Reports Search Engine (MRRSE). This report is an in-depth and professional study of the current situation along with the future growth estimation of the global rubella testing market for the forecast period from 2016-2024. It also offers enterprising information related to regional dynamics and the current situation of the key vendors.
Request For Sample Report: http://www.mrrse.com/sample/1871
The report presents a complete evaluation of the market through accurate introspection of the trajectory of the market by studying the historical data and observing the present as well as future status of the market. It uses powerful analyzing tools like value chain analysis and goes a step ahead by executing a stakeholder analysis for the benefit of the client. Serious market dynamics like challenges, drivers and opportunities are also evaluated in this research study. Based on the report, the World Health Organization (WHO) has informed that in 1996 eighty-three countries have introduced rubella-containing vaccines into their regular national immunization routine; and in 2011, the number increased to 130. The report also revealed that North America towers over the global market for rubella testing, as the region portrayed a stronger demand for diagnosis. Furthermore, the increasing awareness among the public and the federal governments' initiative, supported the growth of the market in North America. Reflecting the same trend was Europe, which stood second in the market for global rubella testing due to increasing awareness among people and the European governments' serious initiative.
A valuable facet of this report is the segmentation of the global market for Rubella testing in terms of applications, and regions. The report segregates the applications in this market into hospitals, commercial and private labs, physician offices and public health labs. Whereas, the sector's active regions are split into North America, Europe and Asia-Pacific. According to the report, the Asia-Pacific region is largely untapped and is predicted to expose bountiful opportunities in the future. This is expected to happen due to rising market penetration in this region along with improved medical infrastructure.
Browse Full Report with TOC: http://www.mrrse.com/rubella-diagnostic-testing-market
Some of the successful vendors who have gained profits from this sector are Abbott Laboratories Inc., Becton, Dickinson and Company, Biomerica, Inc., bioMerieux, Inc., Novartis Diagnostics and Johnson & Johnson Diagnostics Inc.
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE's repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY - 12207
United States Telephone: +1-518-730-0559